Finance

Lists
Why is 539730 down 3,36%?
Dive Deeper
539730:BOM
Fredun Pharmaceuticals Ltd
1 459,00 INR
-3,36%
(-50,65) 1D
15 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539730...
Open
1 535,05 INR
High
1 535,05 INR
Low
1 420,10 INR
Mkt. cap
24,41 მლრდ.
Avg. vol.
18,64 ათ.
Volume
11,77 ათ.
P/E ratio
54,42
52-wk high
1 666,35 INR
52-wk low
454,05 INR
EPS
26,81 INR
Shares outstanding
3,99 მლნ.
No. of employees
736
Open
1 535,05 INR
High
1 535,05 INR
Low
1 420,10 INR
Mkt. cap
24,41 მლრდ.
Avg. vol.
18,64 ათ.
Volume
11,77 ათ.
P/E ratio
54,42
52-wk high
1 666,35 INR
52-wk low
454,05 INR
EPS
26,81 INR
Shares outstanding
3,99 მლნ.
No. of employees
736
News stories
From web sources and news partners
About Fredun Pharmaceuticals Ltd
CEO-
Employees736
Founded1987
Headquarters-
SectorPharmaceutical industry
Websitefredungroup.com
Last report
13 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
2,28 მლრდ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,44 მლრდ.
1,60 მლრდ.
2,13 მლრდ.
2,28 მლრდ.
Cost of goods sold
1,09 მლრდ.
1,15 მლრდ.
1,60 მლრდ.
1,77 მლრდ.
Cost of revenue
1,09 მლრდ.
1,15 მლრდ.
1,60 მლრდ.
1,77 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82,99 მლნ.
81,46 მლნ.
484,22 მლნ.
71,21 მლნ.
Operating expense
163,40 მლნ.
210,93 მლნ.
270,90 მლნ.
216,29 მლნ.
Total operating expenses
1,25 მლრდ.
1,36 მლრდ.
1,87 მლრდ.
1,99 მლრდ.
Operating income
187,30 მლნ.
235,55 მლნ.
252,32 მლნ.
286,78 მლნ.
Other non operating income
17,06 მლნ.
9,97 მლნ.
-49,65 მლნ.
4,92 მლნ.
EBT including unusual items
127,05 მლნ.
140,02 მლნ.
112,48 მლნ.
205,52 მლნ.
EBT excluding unusual items
127,05 მლნ.
140,02 მლნ.
112,48 მლნ.
205,52 მლნ.
Income tax expense
32,74 მლნ.
35,24 მლნ.
53,02 მლნ.
74,20 მლნ.
Effective tax rate
25,77%
25,17%
47,14%
36,10%
Other operating expenses
61,48 მლნ.
111,63 მლნ.
-244,82 მლნ.
109,37 მლნ.
Net income
94,32 მლნ.
104,78 მლნ.
59,45 მლნ.
131,32 მლნ.
Net profit margin
6,57%
6,55%
2,80%
5,77%
Earnings per share
-
-
-
-
Interest and investment income
-
-
6,60 მლნ.
-
Interest expense
-77,31 მლნ.
-105,50 მლნ.
-126,75 მლნ.
-86,18 მლნ.
Net interest expenses
-77,31 მლნ.
-105,50 მლნ.
-120,15 მლნ.
-86,18 მლნ.
Depreciation and amortization charges
18,93 მლნ.
17,84 მლნ.
31,50 მლნ.
35,71 მლნ.
EBITDA
203,86 მლნ.
247,83 მლნ.
272,79 მლნ.
307,24 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები